DehIVa is one of two dehalogenases produced by the soil-and water-borne bacterium Burkholderia cepacia MBA4. It acts to break down short-chain halogenated aliphatic acids through a nucleophilic attack and subsequent hydrolysis of an enzyme±substrate intermediate to remove the halide ions from l-enantiomers substituted at the C2 position (e.g l-2-monochloropropionic acid). Dehalogenases are an important group of enzymes that are responsible for breaking down a diverse range of halogenated environmental pollutants. The dhlIVa gene coding for DehIVa was expressed in Escherichia coli and the protein was puri®ed and crystallized using the hanging-drop method. Crystals grown in PEG 4000 and ammonium sulfate diffracted to 3.1 A Ê . The crystals had a primitive hexagonal unit cell, with unit-cell parameters a = b = 104.2, c = 135.8 A Ê , = = 90, = 120
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. Determining this structure will provide valuable insights into the characterization of the catalytic mechanisms of this group of enzymes.
Introduction
Halogenated organics are an industrially important group of chemicals that in recent decades have been the focus of considerable international attention regarding their detrimental effects on the environment. Their harmful qualities stem from the recalcitrant, carcinogenic and toxic properties of many of these compounds and there is an obvious need to determine strategies for their removal from contaminated systems (Schwarze et al., 1997) . Numerous microorganisms have been isolated that degrade halogenated organics through the action of enzymes called dehalogenases. These enzymes form a diverse group with a broad range of substrate speci®cities and catalytic mechanisms (Slater et al., 1995) . Within this group are the l-2-haloacid dehalogenases (l-2HADs), which catalyze the dehalogenation of the l-enantiomers of C2-substituted shortchain organic acids. The reaction proceeds with the inversion of con®guration at the chiral centre to produce a d-2-hydroxyacid. This stereospeci®city, common throughout dahalogenases, also makes them useful in stereoselective industrial applications in addition to their usefulness in bioremediation.
Burkholderia cepacia MBA4 was isolated by Tsang et al. (1988) by growing cultures containing monobromoacetate (MBA) as the sole carbon source and was shown to produce two dehalogenases, though only the dehalogenase DehIVa was expressed under batch conditions. DehIVa is a member of the l-2HAD family of enzymes and exists as a homodimer with a molecular weight of $45 kDa. Each monomer is 231 amino acids in length (Tsang & Pang, 2000) .
Structural information is available for other dehalogenases, including a number of haloalkane dehalogenases (Streltsov et al., 2003; Oakley et al., 2004; Verschueren et al., 1993) and two haloacid dehalogenases, DhlB and L-DEX YL (Ridder et al., 1997; Hisano et al., 1996) . DehIVa has a high amino-acid sequence identity with the latter two enzymes (40 and 39%, respectively; Slater et al., 1997) . The structures and reaction mechanisms of these enzymes have been determined to be very different from those of the haloalkane dehalogenases (Ridder et al., 1997 (Ridder et al., , 1999 Janssen et al., 2001; Liu et al., 1995) . It should be noted that there is still some uncertainty surrounding the roles of speci®c catalytically important residues; in particular, histidines 20 and 56 and arginines 42 and 156 ( are an important group of enzymes; further structural characterization of related proteins would bene®t our understanding of the groups' reaction mechanisms.
Although there have been a number of rigorous biochemical studies reported regarding this enzyme (Murdiyatmo et al., 1992; Tsang et al., 1988; Tsang & Pang, 2000; Tsang & Sze, 2002) , this is the ®rst report of the crystallization and preliminary crystallographic analysis of the enzyme DehIVa.
Materials and methods

Overexpression and purification of DehIVa
The construct pHKU201 (Tsang & Pang, 2000) bearing the structural gene for DehIVa (hdlIVa) was cloned into Escherichia coli BL21 (DE3). Tsang & Pang (2000) have developed protocols for the overexpression and puri®cation of DehIVa. After con®rming the sequence of the hdlIVa gene, our own protocols were developed from those of Tsang and Pang. In summary, three 2 l cultures were grown in Luria Broth media at 310 K until the OD 600 reached 2.7 and were then induced by the addition of IPTG (to 1 mM). The culture-growth temperature was not modi®ed. After a 4 h induction, cells were spun down at 7500 rev min À1 for 8 min. Cell pellets were harvested and resuspended in 275 ml 50 mM Tris buffer pH 7.4. PMSF was added to a ®nal concentration of 1 mM and the cell suspension then lysed in a French Pressure cell. Cell lysate (270 ml) was then spun down at 15 000 rev min À1 for 15 min to remove the insoluble fraction. The overexpression and puri®cation of DehIVa was monitored as the dominant 25 kDa band on SDS±PAGE as described by Tsang & Pang (2000) . The 25 kDa band was clearly evident after induction with IPTG (Fig. 1a) .
The estimated percentage purity of DehIVa throughout its puri®-cation is summarized in Table 1 . As the pI of DehIVa is $5.1 (determined experimentally), the lysate supernatant was applied to a Q-Sepharose (Pharmacia/P®zer, New York, USA) anion-exchange chromatography column pre-equilibrated with 50 mM Tris pH 7.4. DehIVa was eluted with a linear salt gradient from 0 to 1 M NaCl at ā ow rate of $1.0 ml min À1 for 5 h in the same Tris buffer. Samples containing DehIVa as indicated by SDS±PAGE were combined. This was then treated with two rounds of ammonium sulfate precipitation, ®rst at 50% (the precipitate was discarded) and then at 90% ammonium sulfate. Precipitate was resuspended in 50 mM Tris pH 7.4 and run on a 400 ml Sephacryl (Pharmacia) column. The DehIVa peak was diluted down in a 1:5 ratio with double-distilled H 2 O to a buffer concentration of 10 mM Tris pH 7.4 and then run through a weak anion-exchange column (DEAE Sephacel, Pharmacia) and eluted with a linear salt gradient to 10 mM Tris pH 7.4, 0.5 M NaCl ($0.5 ml min À1 over $10 h). This sample was then desalted, the buffer changed to 30 mM Tris pH 7.4 and spun down in an ultracentrifuge (90 000 rev min À1 for 30 min) to remove an unwanted contaminant. As a ®nal step, the sample ($10 ml) was applied onto a hydroxyapatite (Biorad, Hercules, USA) column (®ve runs of 2 ml) and eluted off with a linear gradient to 70% 30 mM Tris pH 7.4, 90 mM Na 3 PO 4 at 1 ml min À1 for 40 min. The puri®ed eluants were concentrated (6 ml Vivaspin concentrator tube with 3500 Da molecular-weight cutoff; Vivascience, Hanover, Germany) and pooled (5 ml at $1.14 mg ml
À1
; Fig. 1b) . All chromatography except the hydroxyapatite runs was conducted at 277 K (hydroxyapatite at $290 K). In preparation for crystallization trials, the hydroxyapatitepuri®ed DehIVa was desalted and concentrated (6 ml Vivaspin with 3500 Da molecular-weight cutoff) to $7.5 mg ml À1 in a ®nal volume of 800 ml in Tris buffer pH 7.4.
Crystallization
Crystallization screens were set up using JB Screens 2 and 3 from Jena Bioscience (Jena Biosciences, Jena, Germany). The hanging- Table 1 Puri®cation of DehIVa from overexpression in E. coli strain BL21.
Step Purity² (%) drop vapour-diffusion method was used with a drop composed of 1 ml protein solution mixed with 1 ml well solution suspended over 300 ml well solution at room temperature ($293 K). Six morphologically different crystal forms grew within 48 h. The crystallization conditions for each form were as follows.
(1) 30% PEG 4000; (2) 20% PEG 4000, 0.2 M (NH 4 ) 2 SO 4 ; (3) 30% PEG 4000, 100 mM Tris±HCl pH 8.5, 200 mM lithium sulfate; (4) 15% PEG 4000, 100 mM sodium citrate pH 5.6, 200 mM ammonium sulfate; (5) 20% PEG 4000, 100 mM Na MES pH 6.5, 600 mM sodium chloride; (6) ®ne screening of these conditions provided useful diffraction data from crystals of a different morphology grown from 22% PEG 4000 and 0.65 M (NH 4 ) 2 SO 4 in Tris buffer pH 7.4. Photographic images of crystal forms 1, 2 and 6 are presented in Fig. 2 . Crystal forms 3, 4 and 5 were very small and were not amenable to microphotography.
X-ray diffraction analysis
Of the various crystal morphologies, only the hexagonal bipyramidal crystal form 6 (Fig. 2c) provided measurable diffraction data.
The crystals typically grew to $0.2 Â 0.2 Â 0.2 mm over 10±24 h. The crystals did not grow any larger beyond this time. Preliminary data were collected in-house using a Rigaku RUH2R X-ray source with a rotating copper anode equipped with Osmic confocal optics, a MAR Research MAR345 detector and an Oxford Cryosystems 600 Series Cryostream. Crystals were transferred to a 10 ml drop composed of mother liquor modi®ed to include the cryoprotectant glycerol at 20%(v/v) for approximately 5 s prior to¯ash-freezing to 100 K using the Cryostream. An X-ray diffraction image collected in-house is shown in Fig. 3 .
Data processing was conducted using the HKL suite of programs (Otwinowski & Minor, 1997) and a summary of the data-processing statistics are shown in Table 2 . Crystals were found to belong to the primitive hexagonal space group P3 1 21, with unit-cell parameters a = b = 104.2, c = 135.8 A Ê , = = 90, = 120 and a maximum diffraction resolution of $3.1 A Ê . Based upon the Matthews coef®-cient of 4.3 A Ê 3 Da
À1
, we anticipate that the asymmetric unit will contain between one and four monomers of DehIVa. A full structural determination using molecular replacement (with the DhlB structure, PDB code 1qq5) is currently under way.
Crystals were taken to beamline 14-ID-B, BioCARS Facility, Advanced Photon Source (APS) in Argonne for analysis with synchrotron radiation; however, owing to the deterioration of the crystals during transport or handling no usable X-ray diffraction data could be measured. Picture of the diffraction pattern collected in-house from¯ash-frozen bipyramidal crystals of form 6. The exposure time was 10 min, with an oscillation range of 0.25 and a crystal-to-®lm distance of 160 mm. 
